"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
by Ishai Menache, Jeevan Pathuri, David Simchi-Levi and Tom Linton Companies face a variety of complex challenges in designing and optimizing their supply chains. Increasing their resilience ...
Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...
As we dust our shoes of Joe Biden and Kamala Harris and welcome Donald Trump’s return, that milestone offers an important opportunity to assess the lessons of the past four years in order to correct ...
Achieving global regulatory harmonization for biosimilar vaccines and immunotherapies is essential to improving market access ...
It's important for the new administration to understand that controlling inflation requires more than Federal Reserve action. It demands fiscal discipline.